Drug Discovery Articles
Evotec and Takeda enter deal on AD
11 August 2003
Enabling discovery, an overview of biotechnolgy tools
11 August 2003
Seattle Genetics and Genencor extend collaboration
4 August 2003
Therascope financing, name change
28 July 2003
Xcellsyz raises L0.5M from 2nd financing
21 July 2003
Aptanomics appoints Michael Courtney as CEO
7 July 2003
LION Bioscience launches LION Target Engine
30 June 2003
Interlink to liquidate assets
30 June 2003
ScyNexis opens new drug discovery center in the UK
23 June 2003
Isis and Lilly renegotiate Affinitak production deal
16 June 2003
New appointments at Jerini AG
16 June 2003
Acambis and Arrow to work together on novel vaccines
16 June 2003
Millennium to cut 600 jobs; profit by 2006
16 June 2003
Andrew Whitely joins Vitra Bioscience as CEO
9 June 2003
Cyprotex bet hits "the plumber" for L5M
9 June 2003
Amgen acquires 21% stake in Tularik deal
2 June 2003
Virtual Arrays changes name to Vitra Bioscience
26 May 2003
Evotec says 1st qtr up on own expectations
19 May 2003
GSK, Serenex in drug development pact
12 May 2003
Inpharmatica in genomics link with Galapagos
5 May 2003
Hybrigenics acquires Semaia
5 May 2003
Achillion and Phytobiotech in drug discovery alliance
28 April 2003
CytRx makes bid for position in RNAi tech
28 April 2003
GSK announces $500,000 of HIV/AIDS innovation grants
21 April 2003
Telik drug discovery collaboration with Roche
21 April 2003
ComGenex appoints Klaus Frobel as exec VP
14 April 2003
Trancept completes 2nd round of $60M financing
14 April 2003
CompleGen and Berlex sign discovery deal
14 April 2003
EntreMed and Celgene expand partnership
14 April 2003
Cyprotex' losses soar after 1st trading period
7 April 2003
Cyclacel in RNAi collaboration
7 April 2003
Array BioPharma lowers forecasts
7 April 2003
Evotec beats forecasts in 2002, loss widens
31 March 2003
Libraria introduces LUCIA drug discovery expert system
31 March 2003
Dundee Univ $24.5 M deal with six drug majors
24 March 2003
Antex to combine with BioPort
24 March 2003
Entomed and NAEJA Pharma join in screening program
17 March 2003
BioFocus in deal with Mitsubishi Pharma
17 March 2003
Pharmagene sees 12% hike in 2002 sales
17 March 2003
ExonHit extends links with Allergan
3 March 2003
Incyte in $43M deal to buy Maxia Pharma
3 March 2003
Stock Commentary - Week to Feb 17 - Europe
24 February 2003
Achillion promotes Milind Deshpande to VP, drug discovery; names Paul Anderson to advisory board
24 February 2003
Synaptic shareholders OK Lundbeck merger
17 February 2003
LION Bioscience signs global deal with AstraZeneca
17 February 2003
Pharmacopeia's 4th-qtr revenues fall 9%
17 February 2003
New resistance data for B-MS' atazanavir
17 February 2003
Entomed names Jean Combalbert CEO
17 February 2003
Charlotte Herrlinger joins 4SC as VP medicine
10 February 2003
Myriad uncovers new depression gene
10 February 2003
Lundbeck expands collaboration with MindGenix
10 February 2003
OSI in R&D accord with CSHL
10 February 2003
Promotions at AEterna
3 February 2003
Inspire names Joseph Schachle VP, marketing and sales
3 February 2003
Alizyme aims to raise L16.1M in placing
3 February 2003
Cambridge Antibody/Oxford GlycoSciences merger "positive"
3 February 2003
Genetics Co acquires CallistoGen assets
3 February 2003
Demgen on the brink despite improving losses
27 January 2003
Executive moves at LION Bioscience
20 January 2003
Altana R&D progress triggers milestone
20 January 2003
Evotec OAI drug discovery deal with KeyNeurotek AG
20 January 2003
Robust Takeda faces growing competition
13 January 2003
Structural Bio and GeneFormatics to merge
13 January 2003
Biotica raises $5 million venture financing
13 January 2003
Tripos updates 4th-qtr and 2002 year-end
13 January 2003
Canada's AEterna buys Zentaris from Degussa
6 January 2003
Array Bio adjusts growth expectations
6 January 2003
AVANIR revenues up 59%
19 August 2002
New Trigen appointments
19 August 2002
MediGene to spin off cardio drug program
19 August 2002
British Biotech and GenSoft in new JV
19 August 2002
JPMA president: Japan's 3 global pharma challenges
19 August 2002
Pharmacopeia plans restructuring; revenues up 8%
12 August 2002
Zetiq discovers leads active to prevent malignant cancer
12 August 2002
Exelixis and B-MS complete set of cancer targets
12 August 2002
Quark and Fujisawa collaboration broadens
12 August 2002
NeoGenesis signs discovery accord with Pharmacia
5 August 2002
Personal Chemistry's Japan deal
29 July 2002
Compugen extends Pfizer collaboration
29 July 2002
BioFocus and Axxima partnership
29 July 2002
Structural GenomiX/Asahi Kasei collaboration
22 July 2002
MVM makes Norwegian drug discovery investment
15 July 2002
High Throughput/Galderma deal
15 July 2002
GeneFormatics and Arakis collaborate
15 July 2002
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
